Skip to main content

Table 2 Autonomic Symptom Profile scores, median (range).

From: Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests

Domain

All patients

n = 48

non-ERT

n = 18

ERT

n = 30

non-ERT versus ERT, p-value

Healthy controls

n = 48

Patients versus controls, p-value

Orthostatic intolerance

13 (0-35)

14 (0-28)

13 (0-35)

0.96

1.3 (0-25)

0.004

Vasomotor impairment

0 (0-8.2)

0 (0-7.6)

0 (0-8.2)

0.33

0 (0-6.3)

0.017

Secretomotor disorder

1.5 (0-14)

0 (0-7.5)

3 (0-14)

0.000

1.5 (0-7.5)

0.23

Gastroparesis

0 (0-8.4)

0 (0-8.4)

0 (0-5)

0.36

0 (0-3.3)

0.017

Diarrhoea

0 (0-16)

0 (0-8)

0 (0-16)

0.57

0 (0-8)

1.00

Constipation

0 (0-11)

0 (0-6)

0 (0-11)

0.95

0 (0-9)

0.63

Bladder disorder

0 (0-12)

0 (0-10)

0 (0-12)

0.38

0 (0-4)

0.74

Pupillomotor impairment

0.5 (0-4.5)

0.5 (0-2.5)

0.5 (0-4.5)

0.78

0 (0-3)

0.13

Sleep disorder

1.5 (0-7.5)

0 (0-6)

1.5 (0-7.5)

0.002

0 (0-6)

0.06

Syncope

0 (0-4)

0 (0-4)

0 (0-4)

0.29

0 (0-4)

0.31

Sum score

22 (0-78)

21 (0-49)

24 (0-78)

0.30

12 (0-35)

0.005

 

Male patients

n = 15

non-ERT

n = 2

ERT

n = 13

p-value

Male controls

n = 15

p-value

Male sexual failure

0 (0-17)

0.8 (0-1.5)

0 (0-17)

0.93

0 (0-7.5)

0.29

  1. ERT = enzyme replacement therapy